DynaMed®, EBSCO Information Services’ (EBSCO) flagship clinical decision support tool, has partnered with Datapharm to provide technology-enabled solutions to the global life sciences and wider health care sectors. The partnership allows EBSCO and Datapharm to integrate electronic medicines compendium (emc) into DynaMed and DynaMed® and Micromedex® with Watson™.
Datapharm is trusted by medical professionals as a global source for accessible, regulated United Kingdom (UK) medicines information. Emc contains more than 18,000 documents, primarily Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), all of which have been checked and approved by either the UK Medicines and Healthcare Products Regulatory Agency (MHRA) or the European Medicines Agency (EMA).
DynaMed provides the most current, accurate, actionable answers to clinical questions at the point of care. DynaMed and Micromedex with Watson, a single solution through a partnership between EBSCO and IBM, combines curated disease information with top evidence-based drug content. These solutions aim to improve health care outcomes worldwide, offering the most current and accurate, evidence-based content to practicing clinicians.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.Click here to read the original press release.